Bristol Myers reports death of MS patient in autoimmune CAR-T trial, identifies cause of June safety signal

A multiple sclerosis patient has died in a Bristol Myers Squibb autoimmune CAR-T trial. The company also says it now knows what caused June's safety signal in a different CAR-T trial.

Detected & updated continuously · Source: Nebula

Story subjects

Bristol Myers Squibb

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula